Breakthrough: Anti Malaria Drugs Developed by BIOTEC

The National Science and Technology Development Agency (NSTDA) has said that for the first time, Thai researchers have developed their own anti-malaria drugs in Thailand.

Prof. Dr. Yongyuth Yuthavong, a senior researcher at NSTDA, says the researchers from National Center for Genetic Engineering and Biotechnology of Thailand (BIOTEC) have developed a new ‘P 218’ substance that can resist malaria.

Thai researchers applied the knowledge of a medicinal structure that had been found 10 years earlier, and used that to create the substance, which effectively resists malaria.

The NSTDA cooperated with Medicines for Malaria Venture (MMV), the world malaria venture organization, in order to experiment with the pre-clinic levels of the substance, and is using “good laboratory practices”, meaning that it will take more than five years to totally approve the drug.

If the trial for the medicine passes, it will replace the current anti-malaria medicine, since modern strains of malaria seem to have more resistance against the drugs action, especially in the Thai-Burmese border and Thai-Cambodian border areas.



Leave a Reply

Fill in your details below or click an icon to log in: Logo

You are commenting using your account. Log Out /  Change )

Google photo

You are commenting using your Google account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )

Connecting to %s